Health food business Elixinol Wellness reported a loss after tax of A$3.1 million in the six […]
Financial Roundup: Elixinol and Avecho Post Wider Losses; InhaleRx Gets Ethics Approval; Zelira Trims Deficit; Argent Steps Back From Non-Core Work
The Cannabis Observer
·
FOUNDING MEMBERS
First 100 readers lock in 50% off for life
Sector coverage written for operators, not tourists. Reserve founding-member pricing before launch.
- Weekday briefings on regulation, access schemes, and the companies shaping the market
- Full archive and weekly deep-dives once premium goes live
- 50% off the launch price, locked in for as long as your subscription stays active
Join 87 readers already on the waitlist
Avecho
CBD
Clendon Biotech Capital
Elixinol
Health Foods Australia
Healthy Chef
HREC approval
InhaleRx
IRX-616a
Sandoz
Zelira
Related Articles
